Gastroenterology
-
The T-cell clonal response to SARS-CoV-2 vaccination in inflammatory bowel disease patients is augmented by anti-TNF therapy and often deficient in antibody-responders
This article has 24 authors:Reviewed by ScreenIT
-
COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study
This article has 5 authors:Reviewed by ScreenIT
-
Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
This article has 6 authors:Reviewed by ScreenIT
-
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients
This article has 33 authors:Reviewed by ScreenIT
-
Serological Response to BNT162b2 and ChAdOx1 nCoV-19 Vaccines in Patients with Inflammatory Bowel Disease on Biologic Therapies
This article has 14 authors:Reviewed by ScreenIT
-
Impact of biologics and small molecules for inflammatory bowel disease on COVID ‐19‐related hospitalization and mortality: A systematic review and meta‐analysis
This article has 3 authors:Reviewed by ScreenIT
-
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease
This article has 17 authors:Reviewed by ScreenIT
-
Comparison of Endoscopic Activity before and during the Covid Pandemic at a Tertiary Care Hospital in South Punjab
This article has 9 authors:Reviewed by ScreenIT
-
Factors associated with an increased risk of SARS-CoV-2 infection in healthcare workers in aerosol-generating disciplines
This article has 18 authors:Reviewed by ScreenIT
-
Early immunologic response to mRNA COVID-19 vaccine in patients receiving biologics and/or immunomodulators
This article has 8 authors:Reviewed by ScreenIT